Clinical Trial Update: Phase I/II Study of Taxotere,CDDP and 5-FU(TPF) in Pre-treated Pts With Metastatic Esophageal Cancer. [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II study of Taxotere (docetaxel), cisplatin (CDDP), and 5-fluorouracil (TPF) in pre-treated patients with metastatic esophageal cancer; study status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• CISPLATIN (cisplatin)
• Taxotere (docetaxel)

Snippet

Sponsor: Hokkaido Gastrointestinal Cancer Study Group | Conditions: Esophageal Cancer | Phase 1, Phase 2 | Status: COMPLETED